The present invention relates to compounds of formula ##STR00001## wherein R.sup.1 and R.sup.2 are each independently hydrogen or halogen. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with the modulation of CB.sub.1 receptors.